TW200518741A - Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis - Google Patents

Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Info

Publication number
TW200518741A
TW200518741A TW093126695A TW93126695A TW200518741A TW 200518741 A TW200518741 A TW 200518741A TW 093126695 A TW093126695 A TW 093126695A TW 93126695 A TW93126695 A TW 93126695A TW 200518741 A TW200518741 A TW 200518741A
Authority
TW
Taiwan
Prior art keywords
joint
combination
infection
alone
tigecycline
Prior art date
Application number
TW093126695A
Other languages
Chinese (zh)
Inventor
Raymond Thomas Testa
Jason Calhoun
Jon T Mader
Original Assignee
Wyeth Corp
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Univ Texas filed Critical Wyeth Corp
Publication of TW200518741A publication Critical patent/TW200518741A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention is directed to a method for treating bone or bone marrow infections, joint infection or infection of the tissues surrounding the joint by administration of the antibiotic tigecycline alone or in combination with a rifamycin antibiotic. In a preferred embodiment the bone or bone marrow infection causes osteomyelitis. In another embodiment the joint infection or infection of the tissues surrounding the joint causes septic arthritis. The invention is also directed to manufacture of a medicament for treatment of bone and/or bone marrow infections, or joint infections and/or infections in tissues surrounding the joint with tigecycline alone or in combination with rifampin.
TW093126695A 2003-09-05 2004-09-03 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis TW200518741A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50047403P 2003-09-05 2003-09-05

Publications (1)

Publication Number Publication Date
TW200518741A true TW200518741A (en) 2005-06-16

Family

ID=40257280

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093126695A TW200518741A (en) 2003-09-05 2004-09-03 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Country Status (8)

Country Link
AR (1) AR045586A1 (en)
CR (1) CR8324A (en)
GT (1) GT200400176A (en)
MY (1) MY140519A (en)
PA (1) PA8611301A1 (en)
PE (1) PE20050946A1 (en)
TW (1) TW200518741A (en)
ZA (1) ZA200602769B (en)

Also Published As

Publication number Publication date
GT200400176A (en) 2005-10-03
CR8324A (en) 2008-08-26
PA8611301A1 (en) 2005-03-28
PE20050946A1 (en) 2005-11-25
MY140519A (en) 2009-12-31
ZA200602769B (en) 2007-09-26
AR045586A1 (en) 2005-11-02

Similar Documents

Publication Publication Date Title
HK1091754A1 (en) Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
MXPA03008623A (en) Pharmaceutical combinations for the treatment of cancer.
CY1113264T1 (en) STRONTIUM COMBINATIONS FOR THE PREVENTION / TREATMENT OF cartilage and / or bone diseases
MXPA04001876A (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis.
AU2002368274A8 (en) Methods of treating infection by drug resistant bacteria
WO2002041837A3 (en) Treatment of mucositis
HUE041133T2 (en) Methods of administering dalbavancin for treatment of bacterial infections
GB0020504D0 (en) Therapeutic method
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
WO2003061704A3 (en) Combination therapy for the treatment of bacterial infections
MY140519A (en) Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and / or septic arthritis
CY1107038T1 (en) METHOD OF TREATMENT OF BACTERIAL INFECTIONS USING GEMIFLOXACINE OR A SALT AND ANTIBIOTIC B-LACTAMIS
WO2003103699A8 (en) Use of ramoplanin to treat diseases associated with the use of antibiotics
DE60207884D1 (en) MONOBACTAM ANTIBACTERIAL COMPOUNDS AND METHOD OF USE
CY1108472T1 (en) METHOD FOR TREATMENT OF BACTERIAL INFECTIONS USING GEMIFLOXACINE OR A SALT AND ANTI-BACTERIAL AGENT CARBAPENEMIS
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
ES2181593A1 (en) Method for producing bioactive implants that are used as systems for the controlled release of antibiotics
WO2005004880A8 (en) Vaginal compositions for treating pelvic tissue infections and traumas
UA42335A (en) Method for treating purulent wounds
UA37653A (en) Method for treating periappendiceal infiltrate in children
LT2002105A (en) Novel use of siberian fir oil